IDXX Idexx Laboratories Inc /De
In Vitro & In Vivo Diagnostic Substances · Nasdaq · SEC EDGAR official
Market Value*
$42.90B
Revenue (FY)
$4.30B 2025-12-31
Net Income (FY)
$1.06B
P/E (float-based)
40.5
In Vitro & In Vivo Diagnostic Substances · Nasdaq · SEC EDGAR official